We serve (2S)-2-[[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-phenylpropanoyl]amino]-3-phenylpropanoic acid CAS:84889-09-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![(2S)-2-[[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-phenylpropanoyl]amino]-3-phenylpropanoic acid](https://a.dearchem.com/uploads/userup/0/15S2223E-Z30.png)
Chemical Name: (2S)-2-[[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-phenylpropanoyl]amino]-3-phenylpropanoic acid
CAS.NO: 84889-09-8
Molecular Formula:C33H30N2O5
Molecular Weight:534.60200
Synonyms:
Fmoc-Phe-Phe-OH
Fmoc-L-Phe-L-Phe
Fmoc-L-Phe-L-Phe-OH
(S)-2-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-phenylpropanamido)-3-phenylpropanoic acid
L-Phenylalanine,N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-phenylalanyl
Physical and Chemical Properties:
Density: 1.272±0.06 g/cm3
Boiling point:816.1±65.0 °C
Melting point: /
Flash point: /
Refractive index: /
Specification:
Appearance: White Powder
Purity:≥98%
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store at -15ºC.Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:pharmaceutical intermediates.
Contact us for information like (2S)-2-[[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-phenylpropanoyl]amino]-3-phenylpropanoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,L-Phenylalanine,N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-phenylalanyl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Fmoc-L-Phe-L-Phe-OH Use and application,Fmoc-L-Phe-L-Phe-OH technical grade,usp/ep/jp grade.
Related News: As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company’s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.3-Amino-1,2-propanediol manufacturer Biogen last month revived its plans to seek U.S. approval for its aducanumab treatment after announcing in March that it would terminate two large clinical trials for the drug. But some analysts believed FDA approval is highly unlikely.7-Amino-3-methoxy-3-cephem-4-carboxylic acid supplier Biogen last month revived its plans to seek U.S. approval for its aducanumab treatment after announcing in March that it would terminate two large clinical trials for the drug. But some analysts believed FDA approval is highly unlikely.2-Fluoro-5-iodo-4-methylpyridine vendor Biogen last month revived its plans to seek U.S. approval for its aducanumab treatment after announcing in March that it would terminate two large clinical trials for the drug. But some analysts believed FDA approval is highly unlikely.This requires enterprises to have high R & D strength and strategic foresight, keep reserves projects, and seize the market after patents expire.
